New Research Funded by American Lung Association Addresses Gender Differences in Lung Cancer
Lung cancer is the leading cancer killer of women, new LUNG FORCE Research Innovation Project award seeks to identify potential gender differences for lung cancer risk factors
(May 24, 2016) -
For more information please contact:
To better understand the impact of lung cancer in women, the American Lung Association has created a new research award to examine gender differences in lung cancer. Today, the Lung Association announced Sharad Goyal, MD, as the recipient of The LUNG FORCE Research Innovation Project: Lung Cancer in Women Award, funded by the American Lung Association's LUNG FORCE initiative, which raises awareness of the impact of lung cancer in women and critical funds for lung cancer research.
"Lung cancer is the leading cause of cancer death among women, and it is a women's health issue that doesn't often get discussed. The rate of new lung cancer cases has almost doubled among women in the last 38 years, while falling 29 percent among men," said Harold P. Wimmer, National President and CEO of the American Lung Association. "More women than ever are dying of lung cancer, and in order to save lives - we need to understand why."
According to the Lung Association, lung cancer in women indicates that there are potential differences in risk factors, treatment outcomes and prognosis as compared to men. Through this new award—funding $400,000 over three years—the Lung Association seeks innovative approaches to evaluating and addressing these gender differences in lung cancer.
Dr. Goyal is a radiation oncologist at the Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, and is the first-ever recipient of this new research award. His research will seek to determine if radiation exposure from interventional cardiovascular procedures lead to increased risk of lung cancer in women as compared to men.
"Funding from the American Lung Association will allow me to research questions that are important to both lung cancer patients and the medical community, as our findings may reduce the incidence and mortality of lung cancer patients," Dr. Goyal said. "By being able to discuss the risks, benefits and alternatives to medical imaging of the heart, patients will be better informed of their risk of developing cancer."
The LUNG FORCE Research Innovation Project: Lung Cancer in Women Award is among a variety of awards and grants funded by the non-profit organization, building the American Lung Association Research Team of more than 1,500 lung disease researchers the Lung Association has supported over the last 100 years.
"The American Lung Association is committed to investing in promising lung cancer research, as well as research focusing on asthma, COPD, pulmonary fibrosis and other lung diseases," Wimmer said. "Funding medical research is at the core of the American Lung Association's mission to save lives by improving lung health and preventing lung disease."
For media interested in speaking with an expert about lung cancer in women, the American Lung Association Research Team or LUNG FORCE, contact Allison MacMunn at the American Lung Association at [email protected] or 312-801-7628.
About the American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease, through research, education and advocacy. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to improve the air we breathe; to reduce the burden of lung disease on individuals and their families; and to eliminate tobacco use and tobacco-related diseases. For more information about the American Lung Association, a holder of the Better Business Bureau Wise Giving Guide Seal, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.